 |
|
|
| |
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens
|
| |
| |
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
A Luetkemeyer,1 C Mcdonald,2 M Ramgopal,3 S Noviello,4 R Bhore,5 P Ackerman61University of California, San Francisco, CA, USA; 2Tarrant County Infection Disease Associates, Fort Worth, TX, USA; 3Midway Immunology and Research Center, Fort Pierce, FL, USA; 4Bristol-Myers Squibb, Lawrenceville, NJ, USA; 5Bristol-Myers Squibb, Hopewell, NJ, USA; 6Bristol-Myers Squibb, Wallingford, CT, USA.
|
| |
|
|
|
|
|
